|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 8/06/15 Chemours Co 10-Q 6/30/15 100:8M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 640K
2: EX-10.21 Material Contract HTML 110K
3: EX-10.22 Material Contract HTML 117K
4: EX-10.23 Material Contract HTML 67K
5: EX-10.24 Material Contract HTML 36K
10: EX-95 Mine-Safety Disclosure HTML 34K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 35K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 35K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 30K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 30K
70: R1 Document and Entity Information HTML 47K
57: R2 Interim Combined Statements of Operations HTML 76K
(Unaudited)
68: R3 Interim Combined Statements of Operations HTML 31K
(Unaudited) Interim Combined Statements of
Operations (Unaudited) (Parenthetical)
73: R4 Interim Consolidated Statements of Comprehensive HTML 130K
(Loss) Income (Unaudited)
92: R5 Interim Combined Balance Sheets HTML 127K
59: R6 Interim Consolidated Statements of DuPont Company HTML 73K
Net Investment (Unaudited)
67: R7 Interim Consolidated Statements of DuPont Company HTML 31K
Net Investment (Unaudited) (Parenthetical)
52: R8 Interim Combined Statements of Cash Flows HTML 94K
(Unaudited)
43: R9 Interim Combined Statements of Cash Flows HTML 30K
(Unaudited) (Parenthetical)
93: R10 Background and Description of the Business HTML 66K
75: R11 Basis of Presentation HTML 66K
74: R12 Summary of Significant Accounting Policies HTML 50K
80: R13 Relationship with DuPont and Related Entities HTML 73K
81: R14 Research and Development Expense HTML 35K
78: R15 Employee Separation and Asset Related Charges, Net HTML 66K
82: R16 Other Income, Net HTML 53K
69: R17 Income Taxes HTML 37K
71: R18 Accounts and Notes Receivable - Trade, Net HTML 50K
77: R19 Inventories HTML 43K
100: R20 Property, Plant, and Equipment HTML 33K
88: R21 Intangible Assets, Net HTML 64K
63: R22 Other Assets HTML 45K
76: R23 Debt HTML 56K
65: R24 Commitments and Contingent Liabilities HTML 55K
33: R25 Financial Instruments HTML 68K
89: R26 Long-Term Employee Benefits HTML 122K
96: R27 Segment Information HTML 160K
47: R28 Subsequent Events HTML 32K
46: R29 Summary of Significant Accounting Policies HTML 63K
(Policies)
50: R30 Basis of Presentation (Tables) HTML 51K
51: R31 Relationship with DuPont and Related Entities HTML 45K
(Tables)
53: R32 Employee Separation and Asset Related Charges, Net HTML 62K
(Tables)
25: R33 Other Income, Net (Tables) HTML 51K
86: R34 Accounts and Notes Receivable - Trade, Net HTML 44K
(Tables)
61: R35 Inventories (Tables) HTML 40K
64: R36 Intangible Assets, Net (Tables) HTML 58K
38: R37 Other Assets (Tables) HTML 45K
99: R38 Debt (Tables) HTML 46K
17: R39 Financial Instruments (Tables) HTML 73K
54: R40 Long-Term Employee Benefits (Tables) HTML 114K
91: R41 Segment Information (Tables) HTML 155K
36: R42 Background and Description of the Business HTML 51K
(Narrative) (Details)
45: R43 Basis of Presentation (Details) HTML 39K
49: R44 Basis of Presentation (Pro Forma Earnings Per HTML 45K
Share) (Details)
58: R45 Summary of Significant Accounting Policies Summary HTML 30K
of SIgnificant Accounting Policies (Details)
24: R46 Research and Development Expense (Details) HTML 37K
42: R47 Relationship with DuPont and Related Entities HTML 44K
(Related Party Purchases and Sales) (Details)
19: R48 Relationship with DuPont and Related Entities HTML 39K
(Leveraged Services and Corporate Costs) (Details)
90: R49 Relationship with DuPont and Related Entities HTML 39K
(Details)
34: R50 Employee Separation and Asset Related Charges, Net HTML 46K
Employee Separation and Asset Related Charges, Net
(Narrative) (Details)
87: R51 Employee Separation and Asset Related Charges, Net HTML 50K
(Segment Earnings) (Details)
39: R52 Employee Separation and Asset Related Charges, Net HTML 53K
(Restructuring Program schedule) (Details)
55: R53 Other Income, Net (Schedule of Other Income) HTML 49K
(Details)
18: R54 Income Taxes (Details) HTML 45K
22: R55 Accounts and Notes Receivable - Trade, Net HTML 48K
(Narrative) (Details)
48: R56 Accounts and Notes Receivable - Trade, Net HTML 44K
(Schedule of Accounts and Notes Receivable)
(Details)
28: R57 Inventories (Details) HTML 47K
94: R58 Property, Plant, and Equipment Property, Plant and HTML 33K
Equipment (Details)
60: R59 Intangible Assets, Net (Schedule of Other HTML 47K
Intangible Assets) (Details)
79: R60 Intangible Assets, Net (Narrative) (Details) HTML 39K
41: R61 Other Assets (Details) HTML 51K
44: R62 Debt (Components of Long-Term Debt) (Details) HTML 58K
85: R63 Debt (Senior Secured Credit Facilities) (Details) HTML 75K
83: R64 Debt (Senior Unsecured Notes) (Details) HTML 56K
62: R65 Debt (Maturities and Fair Value) (Details) HTML 62K
84: R66 Commitments and Contingent Liabilities HTML 30K
(Guarantees) (Details)
40: R67 Commitments and Contingent Liabilities HTML 72K
(Litigation) (Narrative) (Details)
66: R68 Commitments and Contingent Liabilities HTML 49K
(Environmental) (Narrative) (Details)
95: R69 Financial Instruments (Details) HTML 34K
21: R70 Financial Instruments (Schedule of the Fair Value HTML 51K
of Derivative Instruments) (Details)
32: R71 Long Term Employee Benefits Defined Benefit Plans HTML 35K
(Narrative) (Details)
56: R72 Long-Term Employee Benefits (Mulitemployer Plan) HTML 36K
(Details)
27: R73 Long-Term Employee Benefits (Single and Multiple HTML 74K
Employer Plans) (Details)
98: R74 Long-Term Employee Benefits (Schedules of Net HTML 47K
Periodic Benefit Cost) (Details)
37: R75 Long-Term Employee Benefits (Assumptions) HTML 43K
(Details)
29: R76 Long-Term Employee Benefits (Plan Assets) HTML 77K
(Details)
31: R77 Long-Term Employee Benefits (Cash Flow) (Details) HTML 67K
23: R78 Segment Information (Narrative) (Details) HTML 29K
26: R79 Segment Information (Schedule of Segment HTML 55K
Information) (Details)
72: R80 Segment Information (Reconciliation to HTML 47K
Consolidated Income Statements) (Details)
30: R81 Subsequent Events (Details) HTML 36K
97: XML IDEA XML File -- Filing Summary XML 176K
20: EXCEL IDEA Workbook of Financial Reports XLSX 98K
11: EX-101.INS XBRL Instance -- cc-20150630 XML 2.25M
13: EX-101.CAL XBRL Calculations -- cc-20150630_cal XML 284K
14: EX-101.DEF XBRL Definitions -- cc-20150630_def XML 739K
15: EX-101.LAB XBRL Labels -- cc-20150630_lab XML 1.61M
16: EX-101.PRE XBRL Presentations -- cc-20150630_pre XML 1.01M
12: EX-101.SCH XBRL Schema -- cc-20150630 XSD 193K
35: ZIP XBRL Zipped Folder -- 0001627223-15-000023-xbrl Zip 240K
| CC-Ex.10.24_2015.6.30_Q2 |
Introduction | You have been granted time-vested Restricted Stock Units under The Chemours Company Equity and Incentive Plan (“Plan”) [CONVERSION AWARDS: in substitution of certain of your outstanding award under the E. I. du
Pont de Nemours and Company Equity and Incentive Plan], subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is hereby incorporated by reference. However, to the extent that an Award Term conflicts with the Plan, the Plan shall govern. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in these Award Terms, including any appendices to these Award Terms (hereinafter, collectively referred to as the “Agreement”). A copy of the Plan, and other Plan-related materials, such as the Plan prospectus, are available upon request or on the Merrill Lynch website at: |
Grant
Award Acceptance | You must expressly accept the terms and conditions of your Award as set forth in this Agreement. To accept, log on to Merrill Lynch Benefits OnLine at www.benefits.ml.com, select Equity Plan > Grant Information > Pending Acceptance. |
IF YOU DO NOT ACCEPT YOUR RESTRICTED STOCK UNITS IN THE MANNER INSTRUCTED BY THE COMPANY, YOUR RESTRICTED STOCK UNITS WILL BE SUBJECT TO CANCELLATION. | |
Dividend Equivalents | Dividends payable on the shares represented by your Restricted Stock Units (including whole and fractional Restricted Stock Units) will be allocated to your account in the form of additional Restricted Stock Units (whole and fractional) based upon the closing Stock price on the date of the dividend payment. |
Restricted
Period | You may not sell, gift, or otherwise transfer or dispose of any of the units during the “Restricted Period.” The Restricted Period commences on the Date of Grant and lapses upon the earlier of: (i) “separation from service” (within the meaning of Internal Revenue Code Section 409A) and (ii) death or disability. |
Payment | Restricted
Stock Units shall be paid to you or your beneficiary (or estate, if there is no beneficiary), as applicable, within sixty (60) days of the date on which the Restricted Period on such Restricted Stock Units lapses. Restricted Stock Units are payable in one share of Stock for each whole Restricted Stock Unit and a cash payment for any fraction of a Restricted Stock Unit. The value of each fractional Restricted Stock Unit will be based on the average high and low prices of the Stock as reported on the Composite Tape of the New York Stock Exchange as of the effective date of payment. |
Deferral | You may defer the settlement of this Award in accordance with the Stock Accumulation and Deferred Compensation Plan
for Directors. |
Withholding | Proceeds from vesting of RSUs are subject to various income taxes, including but not limited to Federal, self-employment tax, and City of Wilmington. For U.S. residents, the Company is not required nor does it withhold taxes from your proceeds; however, the Company will report proceeds on a Form 1099-MISC, Non-employee compensation. Grantees are encouraged to consult a tax professional on more specifics. |
Severability | The
provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable. |
Waiver | You acknowledge that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach of this Agreement. |
Requirements | The
Company reserves the right to impose other requirements on your participation in this Agreement, on the Restricted Stock Units and on any shares of Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/6/15 | 8-K | ||
| For Period end: | 6/30/15 | 10-Q/A, S-8 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/27/24 Chemours Co. 10-K 12/31/23 200:50M Donnelley … Solutions/FA 2/10/23 Chemours Co. 10-K 12/31/22 185:39M Donnelley … Solutions/FA 2/11/22 Chemours Co. 10-K 12/31/21 185:36M ActiveDisclosure/FA 2/12/21 Chemours Co. 10-K 12/31/20 182:38M ActiveDisclosure/FA |